Table 2 Demographic and oncologic features of UTUC and UBC
| Â | UTUC | UBC | p-value |
|---|---|---|---|
Age, years (mean ± SD) | 63.89 ± 10.21 | 61.9 ± 10.64 | 0.517 |
BMI (mean ± SD) | 29.17 ± 6.5 | 30.97 ± 7.63 | 0.396 |
Gender, no. (%) | |||
 Male | 16 (84.2%) | 25 (80.6%) | 0.750 |
 Female | 3 (15.8%) | 6 (19.4%) |  |
Comorbidities, no. (%) | |||
Liver disease | |||
 Yes | 0 | 4 (12.9%) | 0.103 |
 No | 19 (100%) | 27 (87.1%) |  |
Diabetes mellitus | |||
 Yes | 2 (10.5%) | 10 (32.3%) | 0.081 |
 No | 17 (89.5%) | 21 (67.7%) |  |
CKD | |||
 Yes | 1 (5.3%) | 3 (9.7%) | 0.577 |
 No | 18 (94.7%) | 28 (90.3%) |  |
Serum creatinine, mg/dL (mean ± SD) | 1.31 ± 0.5 | 1.3 ± 1.2 | 0.994 |
T stage, no. (%) | |||
 T1 | 17 (89.5%) | 7 (22.6%) | < 0.001* |
 T2 | 1 (5.3%) | 8 (25.8) |  |
 T3 | 1 (5.3%) | 13 (41.9) |  |
 T4 | 0 | 3 (9.7%) |  |
N stage, no. (%) | |||
 N0/× | 16 (84.2%) | 18 (58.1%) | 0.107 |
 N1 (single) | 3 (15.8%) | 5 (16.1%) |  |
 N2 (multiple) | 0 | 6 (19.4%) |  |
 N3 | 0 | 2 (6.5%) |  |
Organ confined, no. (%) (T stage ≤ 2, N0/×) | 16 (84.2%) | 12 (38.7%) | 0.002* |
Non-organ confined, no. (%) (T stage > 2, N0/×/+) | 3 (15.8%) | 19 (61.3%) |  |
Cell type final pathology, no. (%) | |||
 Pure TCC | 19 (100%) | 21 (67.7%) | 0.105 |
 TCC with squamous differentiation | 0 | 7 (22.6%) |  |
 TCC with micropapillary component | 0 | 1 (3.2%) |  |
 TCC with sarcomatoid differentiation | 0 | 1 (3.2%) |  |
 TCC with squamous and sarcomatoid differentiation | 0 | 1 (3.2%) |  |
Grade,n(%) | |||
 Low grade | 0 | 1 (3.2%) | 0.429 |
 High grade | 19 (100%) | 30 (96.8%) |  |
Lymphovascular invasion final pathology, no. (%) | |||
 Yes | 14 (73.7%) | 13 (41.9%) | 0.029 |
 No | 5 (26.3%) | 18 (58.1%) |  |